IP Verse

Combination Therapy Of Substituted Oxazolidinones - EP2099453B1

PatentPatent Analysis

EP2099453

BAYER
Application Number
EP07819133A
Filing Date
Oct 19, 2007
Status
Revoked
Sep 16, 2022
Grant Date
Sep 6, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2819699B2
EP3867999B1
EP3358932B2

Bibliography

The patent EP2099453B1 was granted to Bayer on Sep 6, 2017 following the initial filing on Oct 19, 2007 under the application number EP07819133A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZENTIVA GROUPMar 19, 2021 -
HEXAL SANDOZJun 6, 2018ADMISSIBLE
KRAUS & WEISERT PATENTANWALTE PARTGMBBJun 6, 2018ADMISSIBLE
STADA ARZNEIMITTELJun 6, 2018ADMISSIBLE
INTERQUIMJun 6, 2018WITHDRAWN
DENK PHARMAJun 5, 2018ADMISSIBLE
MEDICHEMJun 5, 2018ADMISSIBLE
ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETIJun 4, 2018ADMISSIBLE
GENERICS UKJun 4, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents